Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686062 · ClinicalTrials.gov registry record · NA
Evaluation of a Decision Assisting Tool for Prenatal Testing
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 494
- Enrollment target
NCT00686062: Completed NA study, sponsored by University of California, San Francisco.
NCT00686062 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 494 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00686062, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 494 participants
- Enrollment target
Study Summary
This is a randomized study of an interactive, computerized descision-assisting tool for prenatal testing decision making (PT Tool) versus standard educational booklets distributed to all pregnant women by the State of California (control). We hypothesize that, compared to controls, women randomized to view PT Tool will have greater knowledge about prenatal testing and its potential outcomes and better risk comprehension, and that they will be more satisfied with the intervention and have lower decisional conflict.
Interventions
- OTHER Control - computerized age-appropriate prenatal testing educational brochure
- OTHER PT Tool - interactive, computerized, prenatal testing decision tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 494 participants |
| Start Date | 2001-04 |
| Est. Completion | 2004-04 |
| Phase | NA |
What the finished NCT00686062 record still lists
NCT00686062 is an interventional study that assigns participants to a tested intervention. The registered 494 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which Control - computerized age-appropriate prenatal testing educational brochure is the first listed.
NCT00686062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00686062 about?
NCT00686062 is a clinical study titled "Evaluation of a Decision Assisting Tool for Prenatal Testing". This is a randomized study of an interactive, computerized descision-assisting tool for prenatal testing decision making (PT Tool) versus standard educational booklets distributed to all pregnant women by the State of California (control). We hypothesize that, compared to controls, women randomized ...
What is the current status of trial NCT00686062?
This trial is currently completed. It is a NA study. The enrollment target is 494 participants. The study started on 2001-04. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00686062?
The interventions under investigation include: Control - computerized age-appropriate prenatal testing educational brochure (OTHER), PT Tool - interactive, computerized, prenatal testing decision tool (OTHER).
Who is sponsoring clinical trial NCT00686062?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00686062's enrollment target sits among peer trials
494 213th of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127267 · 495 participants · Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- NCT06400472 · 495 participants · Phase 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia